The industrial biotechnology community spans industry, national laboratories, academic institutions, and investors in the private equity and venture capital (VC) space. From small startups to established multinationals, companies in this field are pushing boundaries and developing game-changing innovations. These organizations are creating functional replacements and drop-in alternatives to traditional petrochemical inputs and products, as well as improving the sustainability of agriculture and food production. They are commercializing a wide array of product types, from small molecules for biofuels and specialty biobased chemicals, to proteins, new foods, novel textiles, and biopolymers.
The third Commercializing Industrial Biotechnology (CIB) conference took place in Los Angeles, CA, on May 2019. The conference highlighted and emphasized the maturation of a new wave of products, bioprocess technologies, global markets, production capacity, and organizations in this sector.
A few of the many inspiring presentations are summarized in this special section of CEP...
Would you like to access the complete CEP Article?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
-
Log in
You must be logged in to view this content. Log in now.
-
AIChE Membership
You must be an AIChE member to view this article. Join now.
Copyright Permissions
Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.